Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Nov 15;491(7424):364-73.
doi: 10.1038/nature11706.

How cancer metabolism is tuned for proliferation and vulnerable to disruption

Almut Schulze  1 , Adrian L Harris
Affiliations
Review

How cancer metabolism is tuned for proliferation and vulnerable to disruption

Almut Schulze et al. Nature. .

Erratum in

  • Nature. 2013 Feb 7;494(7435):130

Abstract

Cancer metabolism has received a substantial amount of interest over the past decade. The advances in analytical tools have, along with the rapid progress of cancer genomics, generated an increasingly complex understanding of metabolic reprogramming in cancer. As numerous connections between oncogenic signalling pathways and metabolic activities emerge, the importance of metabolic reprogramming in cancer is being increasingly recognized. The identification of metabolic weaknesses of cancer cells has been used to create strategies for treating cancer, but there are still challenges to be faced in bringing the drugs that target cancer metabolism to the clinic.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Pathol. 2012 Jun;227(2):146-56 - PubMed
    1. EMBO Rep. 2011 May;12(5):463-9 - PubMed
    1. J Cell Mol Med. 2010 Apr;14(4):771-94 - PubMed
    1. Science. 1956 Feb 24;123(3191):309-14 - PubMed
    1. Proc Natl Acad Sci U S A. 2012 May 1;109(18):6904-9 - PubMed

Publication types